GB1409671A - Cyclopentane derivatives - Google Patents
Cyclopentane derivativesInfo
- Publication number
- GB1409671A GB1409671A GB1040273A GB1040273A GB1409671A GB 1409671 A GB1409671 A GB 1409671A GB 1040273 A GB1040273 A GB 1040273A GB 1040273 A GB1040273 A GB 1040273A GB 1409671 A GB1409671 A GB 1409671A
- Authority
- GB
- United Kingdom
- Prior art keywords
- acid
- cyclopentyl
- hydroxy
- ethyl
- novel compound
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
- 125000001511 cyclopentyl group Chemical class [H]C1([H])C([H])([H])C([H])([H])C([H])(*)C1([H])[H] 0.000 title abstract 2
- 231100000252 nontoxic Toxicity 0.000 abstract 3
- 230000003000 nontoxic effect Effects 0.000 abstract 3
- 150000003839 salts Chemical class 0.000 abstract 3
- 150000001875 compounds Chemical class 0.000 abstract 2
- AWQSAIIDOMEEOD-UHFFFAOYSA-N 5,5-Dimethyl-4-(3-oxobutyl)dihydro-2(3H)-furanone Chemical compound CC(=O)CCC1CC(=O)OC1(C)C AWQSAIIDOMEEOD-UHFFFAOYSA-N 0.000 abstract 1
- FUHCTQMSMAIYDZ-UHFFFAOYSA-N 7-[2-(4-ethyl-3-hydroxyoctyl)-5-hydroxycyclopentyl]heptanoic acid Chemical compound CCCCC(CC)C(O)CCC1CCC(O)C1CCCCCCC(O)=O FUHCTQMSMAIYDZ-UHFFFAOYSA-N 0.000 abstract 1
- 208000001953 Hypotension Diseases 0.000 abstract 1
- 208000036029 Uterine contractions during pregnancy Diseases 0.000 abstract 1
- 239000002253 acid Substances 0.000 abstract 1
- 239000000443 aerosol Substances 0.000 abstract 1
- 229940124630 bronchodilator Drugs 0.000 abstract 1
- 238000006243 chemical reaction Methods 0.000 abstract 1
- 239000003937 drug carrier Substances 0.000 abstract 1
- 230000000694 effects Effects 0.000 abstract 1
- 230000027119 gastric acid secretion Effects 0.000 abstract 1
- 208000021822 hypotensive Diseases 0.000 abstract 1
- 230000001077 hypotensive effect Effects 0.000 abstract 1
- 239000000203 mixture Substances 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
- WGJJROVFWIXTPA-OALUTQOASA-N prostanoic acid Chemical class CCCCCCCC[C@H]1CCC[C@@H]1CCCCCCC(O)=O WGJJROVFWIXTPA-OALUTQOASA-N 0.000 abstract 1
- 230000000638 stimulation Effects 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C405/00—Compounds containing a five-membered ring having two side-chains in ortho position to each other, and having oxygen atoms directly attached to the ring in ortho position to one of the side-chains, one side-chain containing, not directly attached to the ring, a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, and the other side-chain having oxygen atoms attached in gamma-position to the ring, e.g. prostaglandins ; Analogues or derivatives thereof
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2601/00—Systems containing only non-condensed rings
- C07C2601/06—Systems containing only non-condensed rings with a five-membered ring
- C07C2601/08—Systems containing only non-condensed rings with a five-membered ring the ring being saturated
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Abstract
1409671 Prostanoic acid derivatives MAY & BAKER Ltd 28 Feb 1974 [2 March 1973] 10402/73 Addition to 1352691 Heading C2C The novel compound, 7 - [2 - hydroxy - 5- (4 - ethyl - 3 - hydroxyoctyl) - cyclopentyl] heptanoic acid, and its non-toxic salts, are prepared by reduction of 7 - [2 - hydroxy - 5- (4 - ethyl - 3 - hydroxyoct - trans - 1 - enyl) cyclopentyl]heptanoic acid, followed if desired by conversion of the free acid to a non-toxic salt. Pharmaceutical compositions having hypotensive, bronchodilator, gastric acid secretion and stimulation of uterine contraction activity, comprise the above novel compound, or a non- toxic salt thereof, together with a pharmaceutical carrier. The compositions may be administered orally (e.g. by inhalation in aerosol form), rectally, vaginally or parenterally.
Priority Applications (7)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CA103,408A CA989825A (en) | 1970-01-23 | 1971-01-22 | Process for the preparation of cyclopentane derivatives |
GB1040273A GB1409671A (en) | 1973-03-02 | 1973-03-02 | Cyclopentane derivatives |
ZA00741132A ZA741132B (en) | 1973-03-02 | 1974-02-21 | Cyclopentane derivatives |
FR7406886A FR2219784B2 (en) | 1973-03-02 | 1974-02-28 | |
BE141579A BE811795A (en) | 1973-03-02 | 1974-03-01 | |
CH297274A CH557316A (en) | 1973-03-02 | 1974-03-01 | DERIVES DU CYCLOPENTANE. |
US05/502,976 US3935261A (en) | 1970-01-23 | 1974-09-03 | Cyclopentane derivatives |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB1040273A GB1409671A (en) | 1973-03-02 | 1973-03-02 | Cyclopentane derivatives |
Publications (1)
Publication Number | Publication Date |
---|---|
GB1409671A true GB1409671A (en) | 1975-10-15 |
Family
ID=9967178
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
GB1040273A Expired GB1409671A (en) | 1970-01-23 | 1973-03-02 | Cyclopentane derivatives |
Country Status (5)
Country | Link |
---|---|
BE (1) | BE811795A (en) |
CH (1) | CH557316A (en) |
FR (1) | FR2219784B2 (en) |
GB (1) | GB1409671A (en) |
ZA (1) | ZA741132B (en) |
-
1973
- 1973-03-02 GB GB1040273A patent/GB1409671A/en not_active Expired
-
1974
- 1974-02-21 ZA ZA00741132A patent/ZA741132B/en unknown
- 1974-02-28 FR FR7406886A patent/FR2219784B2/fr not_active Expired
- 1974-03-01 CH CH297274A patent/CH557316A/en not_active IP Right Cessation
- 1974-03-01 BE BE141579A patent/BE811795A/xx unknown
Also Published As
Publication number | Publication date |
---|---|
CH557316A (en) | 1974-12-31 |
FR2219784B2 (en) | 1978-08-11 |
ZA741132B (en) | 1975-01-29 |
FR2219784A2 (en) | 1974-09-27 |
BE811795A (en) | 1974-09-02 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
GB1432576A (en) | Substituted phenylacetic acids | |
IE39281B1 (en) | Compisitions for radiographic scanning | |
GB1383939A (en) | Battery electrolyte composition | |
GB1271466A (en) | Thiocarbamic acid derivatives | |
GB1409671A (en) | Cyclopentane derivatives | |
GB1265279A (en) | ||
GB1252329A (en) | ||
GB1374294A (en) | 2-amino-methylphenols | |
GB1409648A (en) | Substituted pyrrolidinemethanol compounds and pharmaceutical compositions thereof | |
GB1490290A (en) | Preparation of penicillanic acid derivatives | |
GB1272606A (en) | Imidazolinyl benzalhydrazone and a process for its preparation | |
GB1361863A (en) | Piperazine derivatives their preparation and pharmaceutical compositions containing them | |
GB1394757A (en) | Lysino-calcium chloride | |
GB1258352A (en) | ||
GB1421089A (en) | Arginine pyroglutamate and a procedure for its preparation | |
IE34590B1 (en) | Phenylethanolamine derivatives | |
GB1471371A (en) | Cyclopenteno-b-pyridine derivative | |
GB1437788A (en) | Therapeutic compositions | |
GB1380265A (en) | Thiazole derivatives | |
CA1028329A (en) | Amine and sodium salts of mono and diesters of 2,5-dihydroxybenzene sulfonic acid | |
GB1509778A (en) | Pharmaceutical composition and dosage units thereof | |
GB1501592A (en) | Pharmaceutical compositions | |
GB1468116A (en) | Esters of 5-n-butyl-pyridine-2-carboxylic acid | |
GB1530154A (en) | Prostaglandin analogues | |
GB1202010A (en) | Prostaglandins and the manufacture thereof |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PS | Patent sealed | ||
PCNP | Patent ceased through non-payment of renewal fee |